Long-term_observation_after_intravesical_metaphylaxis_with_mitomycin_C_in_patients_with_superficial_bladder_tumors._After_transurethral_resection_of_a_superficial_bladder_tumor_63_patients_were_treated_by_chemoprophylaxis_with_mitomycin_C_over_a_period_of_two_years:_33.3_percent_experienced_recurrent_disease_under_metaphylaxis_and_42_patients_who_remained_recurrence-free_during_instillation_therapy_were_observed_further_for_an_average_of_26.4_months._During_this_period_26.2_percent_of_the_patients_showed_recurrences_ranging_between_two_to_forty-four_months_after_completing_instillation._The_majority_of_the_patients_in_whom_recurrent_tumors_developed_also_had_recurrent_tumor_processes_before_the_instillation_therapy_was_begun._Of_the_42_patients_73.8_percent_stayed_recurrence-free_during_the_observation_period_of_twelve_to_fifty-four_months_after_completing_instillation_therapy._In_conclusion,_during_an_average_observation_period_of_50.4_months,_52.4_percent_of_the_patients_in_this_study_showed_recurrences.